Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019 has led to an ongoing global pandemic withmore than 8.5 million cases and 460,000 deaths worldwide. Early reports from Wuhan, China, where the pandemic is believed to have originated, highlighted abnormal coagulation studies in patients, including elevated levels of D-dimer and fibrinogen, prolonged prothrombin time (PT), and mild thrombocytopenia.
Authors
- Stephen Kimani (ORCID: https://orcid.org/0000-0003-0403-1296)
- Nigel S. Key (ORCID: https://orcid.org/0000-0002-8930-4304)
- Jason A. Freed (ORCID: https://orcid.org/0000-0002-9123-8107)
- Richard Lewis Martin (ORCID: https://orcid.org/0000-0001-7117-4954)
- Shonali Midha (ORCID: https://orcid.org/0000-0003-4948-5507)
- Rushad Patell (ORCID: https://orcid.org/0000-0002-8426-3398)
- Michael Jaglal (ORCID: https://orcid.org/0000-0002-4305-2535)
- Natalia Neparidze (ORCID: https://orcid.org/0000-0001-9038-077X)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2025-06-28
- DOI
- https://doi.org/10.17615/r2rd-vf57
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00